In vivo studies demonstrated that levels of both NT-3 and phosphorylated TrkC increased in response to ischemia and that NT-3 is able to promote angiogenesis and to enhance reparative angiogenesis and, thus, enhance blood supply to ischemic limbs [5]. The gene discussed is NTF3; the disease is ischemia.